Evaluating the Efficacy of Therapeutics for Anthrax

Information

• Research Project
• 8082981

• ApplicationId

  8082981

• Core Project Number

  Y1AI6129-6-0-1

• Full Project Number

  Y1AI6129-6-0-1

• Serial Number

  6129

• FOA Number

• Sub Project Id

• Project Start Date

  -

• Project End Date

  -

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2010

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• National Institute of Allergy and Infectious Diseases (NIAID)

This IAA provides for the development and standardization of small animal and non-human primate animal models, and may include efficacy testing of therapeutics, including GLP studies to support product licensure. Therapeutics that are efficacious in small animals may be further tested in non-human primate models.

IC Name

• Activity

  Y01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  776195

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:776195\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

• Organization Department

• Organization DUNS

• Organization City

• Organization State

• Organization Country

• Organization Zip Code

• Organization District